韩国全国新冠疫苗接种活动的影响
韩国利用国家监测系统与国家免疫登记系统链接数据库,评估全国接种ChAdOx1 nCoV-19、BNT162b2、mRNA-1273和Ad26.COV2.S疫苗预防新冠的效果。未接种者年龄调整发病率(5.69/10万人日)为完全接种者(2.13/10万人日)的2.7倍,对SARS-CoV-2感染、重症和死亡的有效性分别为63%、93%和95%;2021年3月至10月估计避免46,508例感染、3,424例重症和718例死亡。
要点
- 未接种者年龄调整发病率为5.69/10万人日,是完全接种者2.13/10万人日的2.7倍。
- 疫苗对SARS-CoV-2感染、重症和死亡的有效性分别为63%、93%和95%。
- 2021年3月至10月估计避免46,508例感染、3,424例重症和718例死亡。
核心结论
- 全国新冠疫苗接种活动对目标人群的重症和死亡显示显著保护,但对SARS-CoV-2感染的保护意外下降,凸显持续监测和评估的重要性。
研究设计与样本
- 将国家监测系统与国家免疫登记系统链接形成大型链接数据库进行评估。
- 计算按疫苗接种状态分层的SARS-CoV-2感染、重症和死亡的年龄调整发病率。
- 基于完全接种与未接种者的发病率比(IRR)计算每周疫苗有效性,IRR=接种者发病率/未接种者发病率。
- 通过比较观察病例与无疫苗接种预测病例,估计随时间累积的SARS-CoV-2结局。
主要发现
- 未接种者年龄调整发病率为5.69/10万人日,是完全接种者2.13/10万人日的2.7倍,对SARS-CoV-2感染的有效性为63%。
- 疫苗对重症和死亡的有效性分别为93%和95%。
- 2021年3月至10月,估计疫苗接种避免46,508例感染、3,424例重症和718例死亡。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We evaluate the overall effectiveness of the nationwide vaccination campaign using ChAdOx1 nCoV-19, BNT162b2, mRNA-1273, and Ad26.COV2.S vaccines in preventing Covid-19 in South Korea. METHODS: The National Surveillance System with the National Immunization Registry were linked to form a large-linked database for assessment. Age-adjusted incidence of SARS-CoV-2 infection, severe disease, and death by vaccination status are calculated. Weekly vaccine effectiveness was calculated based on incidence rate ratio (IRR) between fully-vaccinated and unvaccinated persons, as: IRR = incidence rate of vaccinated / incidence rate of unvaccinated. We estimate the cumulative SARS-CoV-2 outcome overtime comparing the observed case with predicted cases without vaccination. RESULTS: Age-adjusted incidence in unvaccinated persons (5.69 per 100,000 person-day) was 2.7 times the rate in fully vaccinated (2.13 per 100,000 person-day) persons, resulting effectiveness against SARS-CoV-2 infection of 63%. Vaccine effectiveness against severe disease and death were 93% and 95%, respectively. Between March and October 2021, estimated Covid-19 related outcomes averted by vaccinations were: 46,508 infections, 3,424 severe diseases, and 718 deaths. CONCLUSIONS: We found significant protection for national Covid-19 vaccination campaign against Covid-19 severe disease, and death in target populations, but there was an unexpected decreased protection against SARS-CoV-2 infection, highlighting the importance of continued surveillance and assessment.
引用
- Yi S, Choe YJ, Lim DS, et al. Impact of national Covid-19 vaccination Campaign, South Korea. Vaccine. 2022. PMID: 35570077. doi:10.1016/j.vaccine.2022.05.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。